The dramatic re-emergence of tuberculosis has rendered present diagnostic methods inadequate. The PPD skin test detects infection by Mycobacterium tuberculosis, so infection and active disease are not distinguished. Additionally, the PPD test can often produce unreliable results: immunocompromised patients with active tuberculosis are frequently PPD-; healthy, BCG vaccinated people are PPD+, and exposure to non-pathogenic mycobacteria produce a positive PPD result. Tests that diagnose active tuberculosis ultimately depend on recovery of M. tuberculosis in culture and thus are extremely slow. Microscopic examination of stained sputum specimens remains the most rapid method of detecting active tuberculosis. However, this method often produces false negative, or equivocal results. It is thus clear that new diagnostics are necessary. Serology constitutes an attractive alternative technique for tuberculosis diagnostics, because it does not require the presence of infecting organisms in the clinical specimens, is rapid, simple and inexpensive. Lack of success in establishing a sensitive and specific ELISA for tuberculosis to this date is primarily due to limited availability of pure antigens and insufficient knowledge of humoral immune response to tuberculosis in humans. Our overall goal is to identify M. tuberculosis-specific antigens that are recognized by human immune sera and to obtain them in a readily purifiable form, in order to develop ELISA-based serodiagnosis of tuberculosis. Antigens will be identified by screening an M. tuberculosis recombinant phage expression library with human sera from various individuals (HIV+, HIV-, latent infection, active disease, during anti- tubercular therapy, different age groups). Positive clones will be characterized by restriction enzyme analysis and nucleotide sequencing, and on the basis of their reactivity with monoclonal antibodies directed against known mycobacterial antigens. Screening selected clones with M. tuberculosis DNA isolated by genomic substraction with BCG DNA will help identify antigens that are unique to M. tuberculosis. Analysis of selected antigen-expressing clones will establish a panel of antigens that will be used for screening with large numbers of sera by ELISA to begin to establish their diagnostic value. DNA fragments containing full-length genes will be cloned in recombinant gene expression vectors that allow high-level expression as well as simple one-step protein purification. During the period of requested funding, we expect to identify antigens with different specificities: antigens that specifically react with sera from infected versus diseased individuals, that detect infection/or disease in children, that are recognized by individuals coinfected with M. tuberculosis and HIV, that are recognized by antibodies that wane during successful antitubercular treatment, and that are recognized by antibodies that are maintained at detectable serum levels well past completion of therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI036989-02
Application #
2073556
Study Section
Special Emphasis Panel (SRC (85))
Project Start
1994-09-30
Project End
1997-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Public Health Research Institute
Department
Type
DUNS #
City
Newark
State
NY
Country
United States
Zip Code
Shi, Lanbo; Sohaskey, Charles D; North, Robert J et al. (2008) Transcriptional characterization of the antioxidant response of Mycobacterium tuberculosis in vivo and during adaptation to hypoxia in vitro. Tuberculosis (Edinb) 88:1-6
Gennaro, M L; Affouf, M; Kanaujia, G V et al. (2007) Antibody markers of incident tuberculosis among HIV-infected adults in the USA: a historical prospective study. Int J Tuberc Lung Dis 11:624-31
Azzurri, A; Kanaujia, G V; Sow, O Y et al. (2006) Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea. Int J Immunopathol Pharmacol 19:199-208
Shi, Lanbo; Sohaskey, Charles D; Kana, Bavesh D et al. (2005) Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci U S A 102:15629-34
Davidow, Amy; Kanaujia, Ganga V; Shi, Lanbo et al. (2005) Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect Immun 73:6846-51
Ben Amor, Y; Amor, Y B; Shashkina, E et al. (2005) Immunological characterization of novel secreted antigens of Mycobacterium tuberculosis. Scand J Immunol 61:139-46
Kanaujia, G V; Lam, P K; Perry, S et al. (2005) Integration of microscopy and serodiagnostic tests to screen for active tuberculosis. Int J Tuberc Lung Dis 9:1120-6
Shi, Lanbo; North, Robert; Gennaro, Maria Laura (2004) Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung. Infect Immun 72:2420-4
Kanaujia, G V; Motzel, S; Garcia, M A et al. (2004) Recognition of ESAT-6 sequences by antibodies in sera of tuberculous nonhuman primates. Clin Diagn Lab Immunol 11:222-6
Brown, Robin M; Cruz, Orlando; Brennan, Michael et al. (2003) Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guerin vaccination. J Infect Dis 187:513-7

Showing the most recent 10 out of 22 publications